These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17928209)

  • 1. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
    Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program.
    Kiortsis DN; Tzotzas T; Giral P; Bruckert E; Beucler I; Valsamides S; Turpin G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):153-7. PubMed ID: 11590990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight loss resulting from a combined low-fat diet/exercise regimen on low-density lipoprotein particle size and distribution in obese women.
    Varady KA; Lamarche B; Santosa S; Demonty I; Charest A; Jones PJ
    Metabolism; 2006 Oct; 55(10):1302-7. PubMed ID: 16979399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.
    Shin MJ; Hyun YJ; Kim OY; Kim JY; Jang Y; Lee JH
    Int J Obes (Lond); 2006 Oct; 30(10):1529-34. PubMed ID: 16552406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.
    Gazi I; Lourida ES; Filippatos T; Tsimihodimos V; Elisaf M; Tselepis AD
    Clin Chem; 2005 Dec; 51(12):2264-73. PubMed ID: 16223884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans.
    Paik JK; Chae JS; Jang Y; Kim JY; Kim OY; Jeong TS; Lee SH; Lee JH
    Clin Chim Acta; 2010 Apr; 411(7-8):486-93. PubMed ID: 20080080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
    Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M
    Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.
    Oldgren J; James SK; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):699-704. PubMed ID: 17314110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
    Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
    Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects.
    Goldberg Y; Boaz M; Matas Z; Goldberg I; Shargorodsky M
    Clin Nutr; 2009 Feb; 28(1):21-5. PubMed ID: 19019502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lifestyle counseling and combination lipid-modifying therapy on lipoprotein-associated phospholipase A2 mass concentration.
    Reddy KJ; Singh M; Batsell RR; Bangit JR; Miraskar RA; Zaheer MS; Cockerham C; Wegner M
    J Clin Lipidol; 2009 Aug; 3(4):275-80. PubMed ID: 21291824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.